A. Kuki

发表

Helical stability of de novo designed alpha-aminoisobutyric acid-rich peptides at high temperatures.

H. Scheraga, J. D. Augspurger, V. A. Bindra, 1995, Biochemistry.

Pfizer Global Virtual Library (PGVL): a chemistry design tool powered by experimentally validated parallel synthesis information.

Joe Zhongxiang Zhou, Zhengwei Peng, Atsuo Kuki, 2012, ACS combinatorial science.

Zika virus infection in immunocompetent pregnant mice causes fetal damage and placental pathology in the absence of fetal infection

J. Ward, Stephen J. Thomas, A. Kuki, 2018, PLoS pathogens.

Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazide.

A. Kuki, Michael D. Johnson, D. Murphy, 2002, Journal of medicinal chemistry.

Human glucagon receptor antagonists based on alkylidene hydrazides.

A. Kuki, D. Murphy, A. Polinsky, 2002, Bioorganic & medicinal chemistry letters.

Identification of alkylidene hydrazides as glucagon receptor antagonists.

A. Kuki, D. Murphy, A. Polinsky, 2001, Journal of medicinal chemistry.

Electron tunneling paths in proteins.

P. Wolynes, A. Kuki, 1987, Science.

Synthesis of a New Rigid Quinone-Amino Acid and Diels-Alder Extension to Higher Quinones

A. Kuki, S. Kotha, 1993 .

Synthesis and Reactions of 3,4-dihydro-2H-1,4-benzoxazine Derivatives

V. A. Bindra, A. Kuki, S. Kotha, 1994 .

Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.

A. Kuki, S. Butler, S. V. Rahavendran, 2009, Journal of medicinal chemistry.

Spin-forbidden excitation transfer and heavy-atom induced intersystem crossing in linear and cyclic peptides

A. Kuki, D. Anglos, G. Basu, 1993 .

Long-range electronic interactions in peptides : the remote heavy atom effect

A. Kuki, D. Anglos, G. Basu, 1990 .

Long‐Range Electron Transfer in Rigid 310‐Helical Oligopeptides Containing Redox Cyclic a‐Amino Acids

A. Kuki, K. Lang, 1999, Photochemistry and photobiology.

Molecular Optical Rails Based on Aib

J. D. Augspurger, V. A. Bindra, A. Kuki, 1997 .

Photoinduced electron transfer and long-lived charge separation in rigid peptide architectures

V. A. Bindra, A. Kuki, D. Anglos, 1994 .

Evidence for a 3(10)-helical conformation of an eight-residue peptide from 1H-1H rotating frame Overhauser studies.

A. Kuki, G. Basu, 1993, Biopolymers.

Conformational preferences of oligopeptides rich in α‐aminoisobutyric acid. II. A model for the 310/α‐helix transition with composition and sequence sensitivity

A. Kuki, G. Basu, 1992, Biopolymers.

Conformational preferences of oligopeptides rich in α‐aminoisobutyric acid. I. Observation of a 310/α‐helical transition upon sequence permutation

A. Kuki, G. Basu, K. Bagchi, 1991 .

Conformational preferences of oligopeptides rich in alpha-aminoisobutyric acid. III. Design, synthesis and hydrogen bonding in 3(10)-helices.

V. A. Bindra, A. Kuki, 2009, International journal of peptide and protein research.

Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PK.

A. Kuki, S. Butler, Buwen Huang, 2010, Bioorganic & medicinal chemistry letters.

Modelling ab initio non-bonded interactions for sigma bond, pi bond, and lone pair orbitals

A. Kuki, J. Gruschus, 1992 .

LEAP into the Pfizer Global Virtual Library (PGVL) space: creation of readily synthesizable design ideas automatically.

Zhengwei Peng, Atsuo Kuki, Qiyue Hu, 2011, Methods in molecular biology.

New Hamiltonian model for long-range electronic superexchange in complex molecular structures

A. Kuki, J. Gruschus, 1993 .

Improved methods for path integral Monte Carlo integration in fermionic systems

A. Kuki, W. Newman, 1992 .

Partial charges by multipole constraint. Application to the amino acids

A. Kuki, J. Gruschus, 1990 .

Friedel-Crafts Approach to Electron Deficient Cyclic α- Amino Acids

A. Kuki, D. Anglos, S. Kotha, 1992 .

Design and synthesis of novel N-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitors.

A. Kuki, S. Butler, Guy A. McClellan, 2011, Journal of medicinal chemistry.